Clinical Trial Update: Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with nintedanib versus placebo for endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED